FVFlorian Vogt

Florian Vogt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Florian Vogt has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    How people with tinnitus-related insomnia experience group CBT-for-insomnia (CBTi): a thematic analysis

    by Lavinia Cramer, Florian Vogt, Laurence McKenna, Elizabeth Marks

    Objective: Although insomnia often compounds tinnitus, sleeping problems in people experiencing tinnitus are rarely treated. This study investigates the experiences of participants receiving Cognitive Behavioural Therapy for insomnia (CBTi) as part of a randomised controlled trial for managing tinnitus-related insomnia. The aim of this study is to gain detailed insight into participants’ perceptions and experiences of this treatment. Design: Semi-structured interviews were conducted via phone or in-person by one of the two clinical psychologists who facilitated the CBTi sessions. Reflexive thematic analysis with semantic inductive approach was used for analysis to keep the research question theoretically flexible. Study samples: Eight participants (three females, age range 32–69 years) were interviewed six months after CBTi completion. Results: Three superordinate themes were identified: “Common humanity and transcending individual distress,” “Changing the things I can” and “Accepting the things I cannot change.” The group environment helped participants to normalise their experiences. Reliable tinnitus/sleep information and robust behavioural change techniques helped participants to respond and relate to their condition differently. Conclusion: Generally, participants reported long-term benefits from CBTi to treat tinnitus-related insomnia, particularly increased confidence, and getting on with life. CBTi is multi-component, so clinicians need to respond to individual preferences and lifestyles.

  • Open Access

    Cognitive behavioural therapy for insomnia (CBTi) as a treatment for tinnitus-related insomnia: a randomised controlled trial

    by Elizabeth Marks, Christopher Hallsworth, Florian Vogt, Helene Klein, Laurence McKenna

    Insomnia is a significant difficulty and is reported by large proportion of people with tinnitus. Although cognitive behavioural therapy for insomnia (CBTi) might be an effective treatment, no controlled studies had been conducted to date. This randomised controlled trial evaluated the benefits of CBTi on a sample of 102 people with tinnitus-related insomnia. Participants were randomised to 1) CBTi, 2) Audiology-Based Care (ABC) or 3) Sleep Support Group (SSG). Primary outcomes included insomnia, sleep efficiency and total sleep time. Secondary outcomes measured sleep onset latency, sleep quality, tinnitus distress, psychological distress, functioning and quality of life. CBTi was superior at reducing insomnia and increasing sleep efficiency compared to ABC post-intervention and at 6-month follow-up. ABC was superior at reducing insomnia and increasing sleep efficiency compared to SSG. Both CBTi and ABC reported increased total sleep time compared to SSG at 6-month follow. More than 80% of participants in the CBTi group reported clinically meaningful improvements compared to 47% in ABC and 20% for those receiving social support. CBTi was more effective in reducing tinnitus distress and improving sleep quality, functioning and some aspects of mental health. CBTi and ABC offer effective treatments for tinnitus-related sleep disorder but CBTi offers a sizeable benefit.


  • Open Access

    Financial incentives for increasing uptake of HPV vaccinations: A randomized controlled trial.

    by Eleni Mantzari, Florian Vogt, Theresa M. Marteau

    Uptake of human papillomavirus (HPV) vaccinations by 17- to 18-year-old girls in England is below (<35%) target (80%). This trial assesses (a) the impact of financial incentives on uptake and completion of an HPV vaccination program, and (b) whether impacts are moderated by participants' deprivation level. It also assesses the impact of incentives on decision quality to get vaccinated, as measured by attitudes toward the vaccination and knowledge of its consequences. One thousand 16- to 18-year-old girls were invited to participate in an HPV vaccination program: 500 previously uninvited, and 500 unresponsive to previous invitations. Girls randomly received either a standard invitation letter or a letter including the offer of vouchers worth £ 45 (€ 56; $73) for undergoing 3 vaccinations. Girls attending their first vaccination appointment completed a questionnaire assessing decision quality to be vaccinated. Outcomes were uptake of the first and third vaccinations and decision quality. The intervention increased uptake of the first (first-time invitees: 28.4% vs. 19.6%, odds ratio [OR] = 1.63, 95% confidence interval [CI; 1.08, 2.47]; previous nonattenders: 23.6% vs. 10.4%, OR = 2.65, 95% CI [1.61, 4.38]) and third (first-time invitees: 22.4% vs. 12%, OR = 2.15, 95% CI [1.32, 3.50]; previous nonattenders: 12.4% vs. 3%, OR = 4.28, 95% CI [1.92, 9.55]) vaccinations. Impacts were not moderated by deprivation level. Decision quality was unaffected by the intervention. Although the intervention increased completion of HPV vaccinations, uptake remained lower than the national target, which, in addition to cost effectiveness and acceptability issues, necessitates consideration of other ways of achieving it.


  • Open Access

    Using financial incentives to increase initial uptake and completion of HPV vaccinations: protocol for a randomised controlled trial

    by Eleni Mantzari, Florian Vogt, Theresa M Marteau

    Background: HPV vaccination reduces the risk of cervical cancer. Uptake however, of the ‘catch-up’ campaign in England for 17-18 year old girls is below the 80% NHS target. The aim of this randomized controlled trial is to assess the impact of financial incentives on (a) the uptake and completion of an HPV vaccination programme and (b) the quality of the decisions to undertake the vaccination. Method/Design: One thousand (n = 1000) 16-18 year-old girls will be invited to participate in an HPV vaccination programme: Five-hundred (n = 500) will have received a previous invitation to get vaccinated but will have failed to do so (previous non-attenders) and 500 will not have previously received an invitation (first-time invitees). Girls will be randomly selected from eligible participants who are registered with a GP in areas covered by the Birmingham East and North (BEN) and Heart of Birmingham Primary Care Trusts. The two samples of girls will be randomised to receive either a standard vaccination invitation letter or an invitation letter including the offer of vouchers worth £45 for receiving three vaccinations. Girls will also complete a questionnaire to assess the quality of their decisions to be vaccinated. The primary outcome will be uptake of the 1st and 3rd vaccinations. The secondary outcome will be the quality of the decisions to undertake the vaccination, measured by assessing attitudes towards and knowledge of the HPV vaccination. Discussion: The key results will be: a) the effectiveness of financial incentives in increasing uptake of the 1st and 3rd vaccinations; b) the role of participants’ socio-economic status in the moderation of the impact of incentives on uptake; and c) the impact of incentives on the quality of decisions to undertake the HPV vaccinations.


  • Open Access

    The effectiveness of financial incentives for smoking cessation during pregnancy: is it from being paid or from the extra aid?

    by Eleni Mantzari, Florian Vogt, Theresa M Marteau

    Background: Financial incentives appear to be effective in promoting smoking cessation in pregnancy. The mechanisms by which they might operate however, are poorly understood. The present study examines how financial incentives for smoking cessation during pregnancy may work, by exploring pregnant women's experiences of trying to stop smoking, within and outside of a financial incentives scheme. Methods: Thirty-six (n = 36) UK-based pregnant smokers (n = 36), offered standard NHS Stop-Smoking Services, of whom twenty (n = 20) were enrolled in a financial incentives scheme for smoking cessation (n = 20) and sixteen (n = 16) were not, were interviewed about (i) their motivation to stop smoking, and (ii) the factors they perceived as influencing their quitting efforts. Framework Analysis was used to analyse the data. Results: Women in the two groups reported similar reasons for wanting to stop smoking during pregnancy. However, they described dissimilar experiences of the Stop-Smoking Services, which they perceived to have differentially influenced their quit attempts. Women who were incentivised reported using the services more than women who were not incentivised. In addition, they described the motivating experience of being monitored and receiving feedback on their progress. Non-incentivised women reported problems receiving the appropriate Nicotine Replacement Therapy, which they described as having a detrimental effect on their quitting efforts. Conclusion: Women participating in a financial incentives scheme to stop smoking reported greater engagement with the Stop-Smoking Services, from which they described receiving more help in quitting than women who were not part of the scheme. These results highlight the complexity of financial incentives schemes and the intricacies surrounding the ways in which they operate to affect smoking cessation. These might involve influencing individuals' motivation and self-regulation, changing engagement with and provision of support services, or a combination of these.


  • Perceived Effectiveness of Stop Smoking Interventions: Impact of Presenting Evidence Using Numbers, Visual Displays, and Different Timeframes

    by Florian Vogt, Theresa M. Marteau

    This study investigates the impact of visual and numerical representations of effectiveness and different lengths of follow-up upon the perceived effectiveness of stop smoking interventions. This study entails two between-subjects experiments with smokers from the general population. In Experiment 1, U.K. smokers (n = 318) viewed information about a stop smoking intervention that included (a) no effectiveness information, (b) standard numerical effectiveness information, or (c) numerical and visual absolute effectiveness information. In Experiment 2, U.K. smokers (n = 320) viewed numerical and visual absolute effectiveness information about a stop smoking intervention showing either the short-term (1-month) or the long-term (12-month) quit rate with and without intervention. Outcome measures included perceived effectiveness of stop smoking interventions and intentions to use them. In Experiment 1, numerical and visual absolute effectiveness information compared with no effectiveness information resulted in greater perceived effectiveness (Scheffé test, p = .033, Cohen’s d = 0.36) and intentions to use stop smoking interventions (Scheffé test, p = .012, d = 0.43). No differences were detected between standard numerical effectiveness information and no effectiveness information. In Experiment 2, the short-term quit rate compared with long-term quit rate resulted in greater perceived effectiveness, t(318) = 3.2, p = .002, d = 0.35, but not significantly greater intentions to use stop smoking interventions, t(318) = 1.59, p = .11, d = 0.18. Presenting numerical and visual absolute effectiveness information about the short-term effectiveness of stop smoking interventions may increase the use of stop smoking interventions.


  • Open Access

    Crediting Treatments for Good Outcomes That Would Have Happened Anyway

    by F. Vogt, D. Mason, T. M. Marteau

    Background. In some patient populations, many would experience good outcomes even if untreated (described as a small baseline risk). It appears that treatments for populations with small baseline risks are perceived as more effective than those for populations with large baseline risks: in essence, treatments are credited for good outcomes that would have happened anyway. Previous research failed to control for differences in treatment effects. Objective. To evaluate if the baseline risk of developing an acute condition influences the perceived effectiveness of preventive treatments besides the genuine treatment effect. Methods. In study 1 ( n = 1100) and study 2 ( n = 336), general population samples were shown information that systematically differed in size of treatment effect (absolute and relative risk reduction) and the size of the baseline risk of developing a condition. In study 3, medical students ( n = 110) were shown treatments that systematically differed in the size of the baseline risk of developing a condition and the type of condition to be prevented (i.e., migraines, heart disease, and pancreatic cancer). Measures included the perceived effectiveness of treatments, intentions to use these treatments, and numeracy. Results. The baseline risk of developing an acute condition influenced the perceived effectiveness of treatments (study 1: F1,1043 = 66.17, P < 0.001; study 2: F1,329 = 16.574, P < 0.001; study 3: F1,98 =14.31, P < 0.001) and, in turn, intention to use the treatment (study 1: F1,1045 = 7.12, P = 0.008). It caused treatments to be judged as unduly ineffective when the baseline risk was large and vice versa. The influence was independent of treatment effect and was not moderated by numeracy. Conclusions. Treatments for populations with a small baseline risk of developing the condition are perceived as more effective than those for populations with a large baseline risk.


  • What underlies the perception that a medical intervention is effective? An exploratory study among smokers

    by Florian Vogt, Mark Ashworth, Sue Hall, Falko F. Sniehotta, Theresa M. Marteau

    The perceived ineffectiveness of medical interventions is a key predictor of their underuse. This study explores the nature of this perception with regards to a range of medical interventions. Adult smokers (n = 18) completed interviews and questionnaires using the repertory grid technique to elicit personal constructs underlying perceptions of effectiveness of a range of medical interventions (three to stop smoking, three to prevent heart disease, one to reduce pain, one to lose weight, and one to treat depression). Principle components analysis was applied to identify the key underlying dimensions within the constructs. Numerical estimates of the effectiveness of the interventions were also collected from participants to compare them with the published evidence. Constructs clustered around three dimensions: “therapeutic impact,” “behavior-dependent impact,” and “impact facilitates general health.” Smokers perceived impacts that are dependent on the individuals’ behavior to offer small therapeutic impacts, while facilitating individuals’ general health. These three characteristics were attributed to nonbiomedical interventions (e.g., talk-based interventions), while the opposite characteristics were attributed to biomedical interventions (i.e., medication and surgery). Numerical estimates showed that the effectiveness of stop-smoking interventions was underestimated relative to interventions to prevent heart disease. The elicited dimensions provide a basis for communicating evidence concerning the effectiveness of medical interventions, with a view to increasing their use.


  • Open Access

    General practitioners' perceptions of the effectiveness of medical interventions: an exploration of underlying constructs

    by Florian Vogt, David Armstrong, Theresa M Marteau

    Many interventions shown to be effective through clinical trials are not readily implemented in clinical practice. Unfortunately, little is known regarding how clinicians construct their perceptions of the effectiveness of medical interventions. This study aims to explore general practitioners' perceptions of the nature of 'effectiveness'. The design was qualitative in nature using the repertory grid technique to elicit the constructs underlying the perceived effectiveness of a range of medical interventions. Eight medical interventions were used as stimuli (diclophenac to reduce acute pain, cognitive behaviour therapy to treat depression, weight loss surgery to achieve weight loss, diet and exercise to prevent type 2 diabetes, statins to prevent heart disease, stopping smoking to prevent heart disease, nicotine replacement therapy to stop smoking, and stop smoking groups to stop smoking). The setting involved face-to-face interviews followed by questionnaires in London Primary Care Trusts. Participants included a random sample of 13 general practitioners. Analysis of the ratings showed that the constructs clustered around two dimensions: low patient effort versus high patient effort (dimension one), and small impact versus large impact (dimension two). Dimension one represented constructs such as 'success requires little motivation', 'not a lifestyle intervention', and 'health-care professional led intervention'. Dimension two represented constructs such as 'weak and/or minimal evidence of effectiveness', 'small treatment effect for users', 'a small proportion of users will benefit' and 'not cost-effective'. Constructs within each dimension were closely related. General practitioners judged the effectiveness of medical interventions by considering two broad dimensions: the extent to which interventions involve patient effort, and the size of their impact. The latter is informed by trial evidence, but the patient effort required to achieve effectiveness seems to be based on clinical judgement. Some of the failure of evidence-based medicine to be implemented may be more explicable if both dimensions were attended to.